Trial Data Shed Light on ALS Clinical Research
MedPage Today,
Neurology > General Neurology Treatment to improve skeletal muscle function did not meet primary endpoint by Judy George, March…
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS
Overview of attention for article published in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, September 2020
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (89th percentile)
-
High Attention Score compared to outputs of the same age and source (80th percentile)
Readers on
- mendeley
- 79 Mendeley
